- 関
- tosufloxacin
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/07/07 15:37:37」(JST)
[Wiki en表示]
Tosufloxacin
|
Systematic (IUPAC) name |
7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Legal status |
? |
Identifiers |
CAS number |
100490-36-6 Y |
ATC code |
None |
PubChem |
CID 5517 |
UNII |
GHJ553KQPS N |
KEGG |
D02317 Y |
ChEBI |
CHEBI:77573 N |
ChEMBL |
CHEMBL273348 N |
Chemical data |
Formula |
C19H15F3N4O3 |
Mol. mass |
404.34 g/mol |
SMILES
- NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F
|
InChI
-
InChI=1S/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29) N
Key:WUWFMDMBOJLQIV-UHFFFAOYSA-N N
|
N (what is this?) (verify) |
Tosufloxacin is a fluoroquinolone antibiotic. It has a controversial safety profile in relation to other fluoroquinolones. It is associated with severe thrombocytopenia and nephritis, and hepatotoxicity.[1] It is sold in Japan under the brand name Ozex.
See also
- Adverse effects of fluoroquinolones
References
- ^ Rubinstein, E. (2001). "History of quinolones and their side effects.". Chemotherapy. 47 Suppl 3: 3–8; discussion 44–8. doi:10.1159/000057838. PMID 11549783.
Antibacterials: nucleic acid inhibitors (J01E, J01M)
|
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
DHFR inhibitor |
- 2,4-Diaminopyrimidine
- Trimethoprim#
- Brodimoprim
- Tetroxoprim
- Iclaprim†
|
|
Sulfonamides
(DHPS inhibitor) |
Short-
acting |
- Sulfaisodimidine
- Sulfamethizole
- Sulfadimidine
- Sulfapyridine
- Sulfafurazole
- Sulfanilamide
- Sulfathiazole
- Sulfathiourea
|
|
Intermediate-
acting |
- Sulfamethoxazole
- Sulfadiazine#
- Sulfamoxole
|
|
Long-
acting |
- Sulfadimethoxine
- Sulfadoxine
- Sulfalene
- Sulfametomidine
- Sulfametoxydiazine
- Sulfamethoxypyridazine
- Sulfaperin
- Sulfamerazine
- Sulfaphenazole
- Sulfamazone
|
|
Other/ungrouped |
- Sulfacetamide
- Sulfadicramide
- Sulfametrole
|
|
|
Combinations |
- Trimethoprim/sulfamethoxazole#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
1st g. |
- Cinoxacin‡
- Flumequine
- Nalidixic acid
- Oxolinic acid
- Pipemidic acid
- Piromidic acid
- Rosoxacin
|
|
Fluoro-
quinolones |
2nd g. |
- Ciprofloxacin#
- Enoxacin‡
- Fleroxacin‡
- Lomefloxacin
- Nadifloxacin
- Ofloxacin
- Norfloxacin
- Pefloxacin
- Rufloxacin
|
|
3rd g. |
- Balofloxacin
- Grepafloxacin‡
- Levofloxacin
- Pazufloxacin
- Sparfloxacin‡
- Temafloxacin‡
- Tosufloxacin
|
|
4th g. |
- Besifloxacin
- Clinafloxacin†
- Garenoxacin
- Gemifloxacin
- Moxifloxacin
- Gatifloxacin‡
- Sitafloxacin
- Trovafloxacin‡/Alatrofloxacin‡
- Prulifloxacin
|
|
Vet. |
- Danofloxacin
- Difloxacin
- Enrofloxacin
- Ibafloxacin
- Marbofloxacin
- Orbifloxacin
- Pradofloxacin
- Sarafloxacin
|
|
Related (DG) |
- Aminocoumarins: Novobiocin
|
|
|
|
Anaerobic DNA
inhibitors |
Nitro- imidazole derivatives |
- Metronidazole#
- Tinidazole
- Ornidazole
|
|
Nitrofuran derivatives |
- Nitrofurantoin#
- Furazolidone‡
- Nifurtoinol
|
|
|
RNA synthesis |
Rifamycins/
RNA polymerase |
- Rifampicin#
- Rifabutin
- Rifapentine
- Rifaximin
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
gr+f/gr+a (t)/gr-p (c)/gr-o
|
drug (J1p, w, n, m, vacc)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 好酸球性胃腸炎 eosinophilic gastroenteritis
English Journal
- Tosufloxacin Deposits in Compromised Corneas.
- Kim YD1, Kim MK, Wee WR, Choi HJ.
- Optometry and vision science : official publication of the American Academy of Optometry.Optom Vis Sci.2014 Jul 17. [Epub ahead of print]
- PURPOSE: To report the adverse effects of topical tosufloxacin in two patients with corneal deposits in compromised cornea.CASE REPORT: Tosufloxacin was administered topically to a 13-month-old girl after penetrating keratoplasty in the left eye. Three days posttransplantation, corneal precipitation
- PMID 25036547
- [Mn2+-cTMAB-sensitized fluorescent microscopic determination of tosufloxacin tosylate based on a self-ordered ring].
- Deng FY, Huang CX, Liu Y.
- Guang pu xue yu guang pu fen xi = Guang pu.Guang Pu Xue Yu Guang Pu Fen Xi.2014 Feb;34(2):445-9.
- With the development of antimicrobial drugs, drug residue in animal products has a serious potential hazards for the environment and public health, it is urgent to set up drug residue detection method with low detection limit and good selectivity. In our paper, with poly (vinyl alcohol)-124 (PVA-124
- PMID 24822418
- Effects of fluoroquinolone eye solutions without preservatives on human corneal epithelial cells in vitro.
- Oum BS1, Kim NM, Lee JS, Park YM.
- Ophthalmic research.Ophthalmic Res.2014;51(4):216-23. doi: 10.1159/000357976. Epub 2014 Apr 10.
- AIMS: To evaluate the biologic effects of fluoroquinolone eye solutions without preservatives on cultured human corneal epithelial cells in vitro.METHODS: We studied the effect of diverse generations of topical fluoroquinolones such as ofloxacin 0.3%, levofloxacin 0.5%, tosufloxacin 0.3%, moxifloxac
- PMID 24732570
Japanese Journal
- Comparative study of tosufloxacin tosilate fine granules 15% for pediatrics : MEIJI versus Ozex
- ANDO SOICHIRO
- The Japanese journal of antibiotics 70(2), 85-96, 2017-04
- NAID 40021173331
- 小児細菌性外眼部感染症に対するトスフロキサシントシル酸塩水和物点眼液0.3%の臨床的評価および原因菌の薬剤感受性
- 臨床研究・症例報告 マイコプラズマ肺炎へのトスフロキサシントシル酸塩水和物の治療効果について
Related Links
- 中 毒性表皮壊死融解症(Toxic Epidermal Necrolysis: TEN)、皮膚粘膜眼症候群(Stevens-Johnson症 候群)中毒性表皮壊死融解症(Toxic Epidermal Necrolysis:TEN)、皮膚粘膜眼症候群(Stevens-Johnson症候群)があらわれる ...
- Tosufloxacin tosilate 107097-79-0 98% API Raw Materials Treat Sensitive Bacteria Infection
★リンクテーブル★
[★]
- 英
- tosufloxacin
- 化
- トシル酸トスフロキサシン tosufloxacin tosilate、トスフロキサシントシル酸塩
- 商
- オゼックス、トスキサシン、トスフロ